Sign In
Buy NH
$1.35
+0 (+0%)
At Close: Aug 22, 2023
NantHealth Reports 2020 Second Quarter Financial Results
08:05pm, Thursday, 06'th Aug 2020
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2020.
NantHealth to Report 2020 Second-Quarter Financial Results and Host Conference Call on Thursday, August 6
03:47pm, Monday, 03'rd Aug 2020
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 second quarter on Thursday, Aug
NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform
12:00pm, Monday, 27'th Jul 2020
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the acquisition of The OpenNMS Group, Inc. (www.opennms.com), the world’s premier o
NantHealth Points To The Future Of Healthcare
11:38am, Friday, 10'th Jul 2020
Personalized, integrated and evidence-based healthcare is what the company's solutions enable and that's just what the doctor ordered.
NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance
12:00pm, Thursday, 25'th Jun 2020
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer-reviewed journal dedicated to biome
6 Stocks That Could Edge Higher
12:00am, Thursday, 25'th Jun 2020
Stocks Analysis by Harry Boxer covering: Kamada, Allied Healthcare Products Inc, Dynavax Technologies Corporation, Lakeland Industries Inc. Read Harry Boxer's latest article on Investing.com
NantHealth Inc (NASDAQ:NH) Sees Significant Decrease in Short Interest
03:54am, Monday, 22'nd Jun 2020
NantHealth Inc (NASDAQ:NH) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totalling 258,400 shares, a drop of 15.4% from the May 31st total o
The Global Precision Medicine Software Market will grow by USD 882.65 mn during 2020-2024
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on developmental therapeutics for immunotherapy, molecula
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on deve
NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow
03:24pm, Tuesday, 16'th Jun 2020
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will exhibit at the online America’s Health Insurance Plans (AHIP) Institute & E
Edited Transcript of NH earnings conference call or presentation 7-May-20 8:30pm GMT
04:18am, Friday, 12'th Jun 2020
Q1 2020 NantHealth Inc Earnings Call
NantHealth (NH) Looks Good: Stock Adds 9.1% in Session
12:55pm, Thursday, 11'th Jun 2020
NantHealth (NH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Do Hedge Funds Love NantHealth, Inc. (NH)?
09:29pm, Thursday, 04'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
In Recognition of the Challenges Providers Are Facing, NantHealth is Offering Free Access to NaviNet AllPayer for a Limited Time
08:30pm, Friday, 08'th May 2020
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will offer free access to the NaviNet AllPayer platform through May 31, 2020. There is no obligation
